MedPath

UNIVERSITY OF SOUTHERN CALIFORNIA

UNIVERSITY OF SOUTHERN CALIFORNIA logo
🇺🇸United States
Ownership
Private
Established
1880-01-01
Employees
10K
Market Cap
-
Website
http://startusc.com

Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities

Completed
Conditions
Relapsing Remitting Multiple Sclerosis
First Posted Date
2011-10-20
Last Posted Date
2013-04-04
Lead Sponsor
University of Southern California
Target Recruit Count
10
Registration Number
NCT01456416
Locations
🇺🇸

USC MS Comprehensive Care Center & Research Group, Los Angeles, California, United States

Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Main Study)

Not Applicable
Completed
Conditions
Acute Respiratory Infections (ARIs)
First Posted Date
2011-10-19
Last Posted Date
2024-05-23
Lead Sponsor
University of Southern California
Target Recruit Count
248
Registration Number
NCT01454947
Locations
🇺🇸

Altamed Anaheim Lincoln, Anaheim, California, United States

🇺🇸

Altamed Bell Clinic, Bell, California, United States

🇺🇸

Altamed DVL El Monte, El Monte, California, United States

and more 52 locations

Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Pilot Study)

Not Applicable
Completed
Conditions
Acute Respiratory Infections (ARIs)
First Posted Date
2011-10-19
Last Posted Date
2017-04-04
Lead Sponsor
University of Southern California
Target Recruit Count
28
Registration Number
NCT01454960
Locations
🇺🇸

Northwestern Medical Faculty Foundation General Internal Medicine Clinic, Chicago, Illinois, United States

Strength Training and Nutrition Development for African American Youth

Not Applicable
Completed
Conditions
Cardiovascular Risk
Obesity
Type 2 Diabetes
Cancer
Interventions
Behavioral: Nutrition
Behavioral: Strength Training & Nutrition
First Posted Date
2011-09-27
Last Posted Date
2017-03-31
Lead Sponsor
University of Southern California
Target Recruit Count
62
Registration Number
NCT01441323
Locations
🇺🇸

Veronica Atkins Lifestyle Intervention Laboratory, Los Angeles, California, United States

The HJ MILE HIV Prevention Intervention for Post-incarcerated Men

Phase 3
Completed
Conditions
HIV
Risk Reduction Behavior
Interventions
Behavioral: MILE intervention
First Posted Date
2011-09-01
Last Posted Date
2018-10-12
Lead Sponsor
University of Southern California
Target Recruit Count
212
Registration Number
NCT01427543
Locations
🇺🇸

Center for Health Justice, Los Angeles, California, United States

Yoga Empowers Seniors Study

Not Applicable
Completed
Conditions
Healthy Older Adults
Interventions
Behavioral: yoga
First Posted Date
2011-08-05
Last Posted Date
2016-11-16
Lead Sponsor
University of Southern California
Target Recruit Count
27
Registration Number
NCT01411059
Locations
🇺🇸

UCLA, Los Angeles, California, United States

Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer

Phase 1
Terminated
Conditions
Adult Spinal Cord Neoplasm
Spinal Bone Metastases
Spinal Cord Compression
Interventions
Procedure: musculoskeletal complications management/prevention
Procedure: bone graft
Procedure: quality-of-life assessment
Other: questionnaire administration
First Posted Date
2011-08-02
Last Posted Date
2014-02-06
Lead Sponsor
University of Southern California
Target Recruit Count
1
Registration Number
NCT01407341
Locations
🇺🇸

University of Southern California, Los Angeles, California, United States

Trial to Examine Text-message Based mHealth in Emergency Department Patients With Diabetes

Not Applicable
Completed
Conditions
Diabetes
Interventions
Other: Daily text messages
First Posted Date
2011-07-27
Last Posted Date
2013-06-19
Lead Sponsor
University of Southern California
Target Recruit Count
200
Registration Number
NCT01403831
Locations
🇺🇸

University of Southern California, Los Angeles, California, United States

Oral Hydration for Mild to Moderate Hyperglycemia in the Emergency Department

Phase 1
Completed
Conditions
Hyperglycemia
Interventions
Other: Intravenous normal saline
Other: Oral water
First Posted Date
2011-07-25
Last Posted Date
2011-07-25
Lead Sponsor
University of Southern California
Target Recruit Count
80
Registration Number
NCT01401634
Locations
🇺🇸

University of Southern California, Los Angeles, California, United States

Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder

Phase 2
Terminated
Conditions
Recurrent Bladder Cancer
Stage III Bladder Cancer
Stage IV Bladder Cancer
Transitional Cell Carcinoma of the Bladder
Interventions
Drug: docetaxel
Drug: lapatinib ditosylate
Other: immunohistochemistry staining method
Genetic: fluorescence in situ hybridization
Other: laboratory biomarker analysis
First Posted Date
2011-06-27
Last Posted Date
2018-05-16
Lead Sponsor
University of Southern California
Target Recruit Count
15
Registration Number
NCT01382706
Locations
🇺🇸

USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath